Legal battle over medication abortion intensifies with conflicting rulings and potential Supreme Court involvement.
TL;DR Summary
Two federal court rulings on medication abortion were issued on Friday, with one halting the FDA's approval of mifepristone and the other ordering the drug to remain available in 17 states and the District of Columbia. The rulings did not directly address the right to an abortion, but the Texas judge's opinion suggested embryos could have individual rights. The conflicting rulings set up a potential Supreme Court battle and come after the court's ruling last summer that overturned Roe v. Wade.
- Rival rulings on medication abortion hypercharge the post-Roe legal war CNN
- Judge Invalidates F.D.A. Approval of the Abortion Pill Mifepristone The New York Times
- Abortion pill case likely heads to SCOTUS after two judges issue conflicting rulings MSNBC
- Opinion: A judge's attempt to restrict medication abortion nationwide shows extremists aren't done yet Los Angeles Times
- Reaction to Texas Abortion Pill Ruling: Outrage, and Muted Praise The New York Times
Reading Insights
Total Reads
0
Unique Readers
10
Time Saved
7 min
vs 8 min read
Condensed
95%
1,502 → 81 words
Want the full story? Read the original article
Read on CNN